General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 3rd communication: effects on respiratory and cardiovascular systems.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples